Singular Genomics Enters Into Agreement To Be Acquired By Deerfield For $20 In Cash per Share
Singular Genomics Enters Into Agreement To Be Acquired By Deerfield For $20 In Cash per Share
Singular Genomics Systems, Inc. (NASDAQ:OMIC) ("Singular Genomics" or the "Company"), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced that it has entered into a definitive merger agreement whereby an affiliate of Deerfield Management Company, L.P. will acquire Singular Genomics in an all-cash transaction for $20.00 per share.
Singular Genomics Systems, Inc. (納斯達克:OMIC)（"Singular Genomics"或"公司"）是一家利用新型下一代測序（NGS）和空間多組學技術來賦能研究人員和臨牀醫生的公司，今天宣佈已達成一項最終合併協議，該協議將由德爾菲德管理公司（Deerfield Management Company, L.P.）的關聯方以現金交易的方式以每股20.00美元收購Singular Genomics。
The $20.00 per share represents 254% premium to the last closing share price for Singular's common stock prior to the September 12, 2024 public disclosure of Deerfield's initial acquisition proposal.
每股20.00美元相較於Singular普通股在2024年9月12日德爾菲德首次收購提案公開之前的最後收盤股價溢價254%。
譯文內容由第三人軟體翻譯。
